Crovalimab,Eculizumab,gilteritinib
Roche,Chugai Pharmaceutical,AstraZeneca,astellas
['rova,(-approval),(-microvascular)', 'alexander']
alexander r th presentated data from commodore2 showing crovalimab was non-inferior to eculizumab in terms of hemolysis control, and adverse events in tx naive #pnh patients. drug is given as self sc injection 4 weekly. #eha2023 #bmfsm 2/3 
🇮🇪🧛🏻‍♀️Haematologist @nih_nhlbi l via  @ucdmedicine @trinitymed1 l Lover of 🚀🐷🖖🍷l #SAA #IBMFS #telomeres #CHIP #MDS #AML #HSCT #VEXAS l Comments mine.